
Samuel A. Acquah
Examiner (ID: 3913)
| Most Active Art Unit | 1711 |
| Art Unit(s) | 1503, 1711, 1774, 2899, 1207, 1754 |
| Total Applications | 2690 |
| Issued Applications | 2329 |
| Pending Applications | 91 |
| Abandoned Applications | 269 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18610866
[patent_doc_number] => 20230277596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => EXOSOME COMPOSITION AND METHOD OF MANUFACTURE
[patent_app_type] => utility
[patent_app_number] => 18/051663
[patent_app_country] => US
[patent_app_date] => 2022-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18051663
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/051663 | EXOSOME COMPOSITION AND METHOD OF MANUFACTURE | Oct 31, 2022 | Pending |
Array
(
[id] => 18692944
[patent_doc_number] => 20230323303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => HAEMATOPOIETIC STEM/PROGENITOR CELLS
[patent_app_type] => utility
[patent_app_number] => 18/045296
[patent_app_country] => US
[patent_app_date] => 2022-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19059
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18045296
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/045296 | HAEMATOPOIETIC STEM/PROGENITOR CELLS | Oct 9, 2022 | Pending |
Array
(
[id] => 18649747
[patent_doc_number] => 20230295567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => METHODS FOR CULTURING CELLS AND KITS AND APPARATUS FOR SAME
[patent_app_type] => utility
[patent_app_number] => 18/045137
[patent_app_country] => US
[patent_app_date] => 2022-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 107482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18045137
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/045137 | METHODS FOR CULTURING CELLS AND KITS AND APPARATUS FOR SAME | Oct 6, 2022 | Pending |
Array
(
[id] => 18418532
[patent_doc_number] => 20230172990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => EXTRACELLULAR VESICLE COMPOSITIONS AND THE USE THEREOF IN THE TREATMENT OF SKIN CONDITIONS AND IN IMMUNE MODULATION
[patent_app_type] => utility
[patent_app_number] => 17/899151
[patent_app_country] => US
[patent_app_date] => 2022-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16989
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17899151
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/899151 | EXTRACELLULAR VESICLE COMPOSITIONS AND THE USE THEREOF IN THE TREATMENT OF SKIN CONDITIONS AND IN IMMUNE MODULATION | Aug 29, 2022 | Pending |
Array
(
[id] => 18141304
[patent_doc_number] => 20230015146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => NUCLEIC ACID PRODUCTS AND METHODS OF ADMINISTRATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/820473
[patent_app_country] => US
[patent_app_date] => 2022-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 121748
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820473
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/820473 | NUCLEIC ACID PRODUCTS AND METHODS OF ADMINISTRATION THEREOF | Aug 16, 2022 | Abandoned |
Array
(
[id] => 18182093
[patent_doc_number] => 20230042822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => METHODS FOR DIFFERENTIATING MESENCHYMAL STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/817757
[patent_app_country] => US
[patent_app_date] => 2022-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32855
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817757
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/817757 | METHODS FOR DIFFERENTIATING MESENCHYMAL STEM CELLS | Aug 4, 2022 | Abandoned |
Array
(
[id] => 20202490
[patent_doc_number] => 12405268
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-02
[patent_title] => Lymphocyte-based morphometric test for alzheimer's disease
[patent_app_type] => utility
[patent_app_number] => 17/873344
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 0
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17873344
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/873344 | Lymphocyte-based morphometric test for alzheimer's disease | Jul 25, 2022 | Issued |
Array
(
[id] => 18149419
[patent_doc_number] => 20230023276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => 3-D BIOPRINTING COMPRISING BIOLOGICALLY-RELEVANT MATERIALS AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 17/862892
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6688
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17862892
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/862892 | 3-D BIOPRINTING COMPRISING BIOLOGICALLY-RELEVANT MATERIALS AND RELATED METHODS | Jul 11, 2022 | Pending |
Array
(
[id] => 19716229
[patent_doc_number] => 12201745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => Vascular extracellular matrix hydrogel
[patent_app_type] => utility
[patent_app_number] => 17/808423
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 24
[patent_no_of_words] => 17299
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17808423
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/808423 | Vascular extracellular matrix hydrogel | Jun 22, 2022 | Issued |
Array
(
[id] => 18058327
[patent_doc_number] => 20220389413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => BIOLOGICAL LIBRARIES AND METHODS OF PREPARING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/830637
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17830637
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/830637 | BIOLOGICAL LIBRARIES AND METHODS OF PREPARING AND USING SAME | Jun 1, 2022 | Pending |
Array
(
[id] => 17981206
[patent_doc_number] => 20220347242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => ANTICANCER COMPOSITION COMPRISING TUMOR-SPECIFIC ONCOLYTIC ADENOVIRUS AND IMMUNE CHECKPOINT INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/745768
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745768
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/745768 | ANTICANCER COMPOSITION COMPRISING TUMOR-SPECIFIC ONCOLYTIC ADENOVIRUS AND IMMUNE CHECKPOINT INHIBITOR | May 15, 2022 | Pending |
Array
(
[id] => 17828422
[patent_doc_number] => 20220265726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => USE OF VETO CELLS FOR THE TREATMENT OF SICKLE CELL DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/737052
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24860
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737052
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/737052 | USE OF VETO CELLS FOR THE TREATMENT OF SICKLE CELL DISEASE | May 4, 2022 | Abandoned |
Array
(
[id] => 17805893
[patent_doc_number] => 20220257728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => USE OF HISTONE DEUBIQUITINASE IN PREPARING DRUG FOR PREVENTING AGING AND TREATING AGING-RELATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/732478
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3407
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17732478
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/732478 | USE OF HISTONE DEUBIQUITINASE IN PREPARING DRUG FOR PREVENTING AGING AND TREATING AGING-RELATED DISEASES | Apr 27, 2022 | Abandoned |
Array
(
[id] => 17807784
[patent_doc_number] => 20220259619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY
[patent_app_type] => utility
[patent_app_number] => 17/726833
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -81
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17726833
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/726833 | COMPOSITIONS AND METHODS FOR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY | Apr 21, 2022 | Pending |
Array
(
[id] => 19674506
[patent_doc_number] => 12186344
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-07
[patent_title] => Cell populations having immunoregulatory activity, method for isolation and uses
[patent_app_type] => utility
[patent_app_number] => 17/659157
[patent_app_country] => US
[patent_app_date] => 2022-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 27
[patent_no_of_words] => 18096
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17659157
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/659157 | Cell populations having immunoregulatory activity, method for isolation and uses | Apr 12, 2022 | Issued |
Array
(
[id] => 20220178
[patent_doc_number] => 20250283109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-11
[patent_title] => PLASMIDS AND METHODS OF PRODUCTION OF ADENO-ASSOCIATED VIRUSES
[patent_app_type] => utility
[patent_app_number] => 18/284404
[patent_app_country] => US
[patent_app_date] => 2022-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18284404
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/284404 | PLASMIDS AND METHODS OF PRODUCTION OF ADENO-ASSOCIATED VIRUSES | Apr 12, 2022 | Pending |
Array
(
[id] => 17749903
[patent_doc_number] => 20220228108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => CELL CULTURE BASE MATERIAL AND CELL CULTURE BASE MATERIAL WITH CELLS
[patent_app_type] => utility
[patent_app_number] => 17/658446
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17658446
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/658446 | CELL CULTURE BASE MATERIAL AND CELL CULTURE BASE MATERIAL WITH CELLS | Apr 7, 2022 | Abandoned |
Array
(
[id] => 19439368
[patent_doc_number] => 12089589
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => Irradiation of red blood cells and anaerobic storage
[patent_app_type] => utility
[patent_app_number] => 17/702586
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 32
[patent_no_of_words] => 8665
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17702586
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/702586 | Irradiation of red blood cells and anaerobic storage | Mar 22, 2022 | Issued |
Array
(
[id] => 18163834
[patent_doc_number] => 20230030428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => STEM CELL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/691028
[patent_app_country] => US
[patent_app_date] => 2022-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691028
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/691028 | STEM CELL COMPOSITION | Mar 8, 2022 | Abandoned |
Array
(
[id] => 17657367
[patent_doc_number] => 20220177832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => CELL CULTURE MEDIUM FOR EUKARYOTIC CELLS
[patent_app_type] => utility
[patent_app_number] => 17/677163
[patent_app_country] => US
[patent_app_date] => 2022-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11235
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17677163
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/677163 | Cell culture medium for eukaryotic cells | Feb 21, 2022 | Issued |